创新药概念延续强势 塞力医疗2连板

Core Viewpoint - The innovative drug sector continues to show strong performance, with companies like Sali Medical achieving consecutive gains, driven by supportive government policies aimed at enhancing the development of innovative drugs [1] Group 1: Market Performance - Sali Medical has achieved two consecutive trading gains [1] - Microchip Biotech has increased by over 10% [1] - Other companies such as Huahai Pharmaceutical, Weiming Pharmaceutical, Anglikang, and Yuekang Pharmaceutical also experienced upward movement [1] Group 2: Government Support - The National Healthcare Security Administration and the National Health Commission have issued measures to support the high-quality development of innovative drugs [1] - The measures include support for innovative drugs to enter the basic medical insurance drug list and the commercial health insurance innovative drug list [1] - The establishment of a commercial health insurance innovative drug list is also part of the new measures [1]